The U.S. Food and Drug Administration has not approved cannabis for any use in animals, and the agency cannot ensure the safety or effectiveness of these products. For these reasons, FDA cautions pet owners against the use of such products and recommends that owners talk with their veterinarian about appropriate treatment options.
Here are some common questions about cannabis and cannabis-derived products (click to see the answers):
Additional information is at the links below:
The AVMA provides tools for individuals and practices facing cyberbullying. The log in page for members to access a free helpline is https://www.avma.org/
Improve how we communicate with our clients. Training videos demonstrate how we can improve our client interactions using key language to effect better care for our patients. Click here to learn more.
As of July 1, 2018 in Nebraska, a veterinarian licensed under the Veterinary Medicine and Surgery Practice Act is required to report a dispensed prescription of controlled substances listed on Schedule II, Schedule III, or Schedule IV pursuant to section 28-405. (Neb. Rev. Stat. § 71-2454 (4)). (Here is a link to a list of all controlled substances in Nebraska — veterinarians are required to report a dispensed prescription of controlled substances listed on Schedule II, Schedule III, or Schedule IV).
The Nebraska prescription drug monitoring program (PDMP) is developed through legislative bills passed by the Nebraska Legislature in 2011, with system enhancements made in 2016 and 2017.
Here are some resources to help you comply with the PDMP for veterinarians: